Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT03010735
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 150 participants
- Registry
-
NCT03010735
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03010735. Randomized; quadruple masking; primary purpose prevention. Start 2015-06 (registry gives no type); primary completion 2017-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)
- Condition
- Kidney Failure, Chronic
- Intervention (Dietary supplement)
- probiotics
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- China Agricultural University
- Collaborator
- Peking University Aerospace Center Hospital
- Collaborator
- General Hospital of Chinese Armed Police Forces
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- Beijing Biostats Technology Co. Ltd.
- Collaborator
- Beijing Heyiyuan Biotech Co. Ltd.
Record details
- Record id
cardio:ct-nct03010735- Content hash
8f23d22cfa6b1fdc2a1164e3f5b28b894ce6e56266cbd9565e77781306e79c1a